Global Genome Editing Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	163 Pages	TechNavio	March, 2024	INF18690634

Best Price Guarantee
Price	from $2,500
Length	163 Pages
Publisher	TechNavio
Published Date	March, 2024
SKU	INF18690634

Global Genome Editing Market 2024-2028

The genome editing market is forecasted to grow by USD 7.23 bn during 2023-2028, accelerating at a CAGR of 15.88% during the forecast period. The report on the genome editing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rapid technological advancements in genome editing, increasing demand for personalized medicine, and the emergence of novel gene editing platforms.

Technavio's genome editing market is segmented as below:

By End-user

Pharmaceutical and biotechnology companies
Academic institutes and research laboratories
CRO

By Delivery Mode

Ex-vivo
In-vivo

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rise of CRISPR-based diagnostics as one of the prime reasons driving the genome editing market growth during the next few years. Also, the growing integration of gene editing with AI and data analytics and increasing adoption of genome editing in agriculture and livestock will lead to sizable demand in the market.

The report on the genome editing market covers the following areas:

Genome editing market sizing
Genome editing market forecast
Genome editing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genome editing market vendors that include AstraZeneca PLC, Caribou Biosciences Inc., Cellectis SA, Cibus, Danaher Corp., Editas Medicine Inc., Egenesis, GenScript Biotech Corp., Horizon Discovery Ltd., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs Inc., OriGene Technologies Inc., PerkinElmer Inc, Precision BioSciences Inc., Sangamo Therapeutics Inc., Takara Bio Inc., Tecan Trading AG, and Thermo Fisher Scientific Inc.. Also, the genome editing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary - Chart on Market Segmentation by Delivery Mode; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global genome editing market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global genome editing market 2018 - 2022 ($ billion); 4.2 End-user Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion); 4.3 Delivery mode Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Delivery mode Segment 2018 - 2022 ($ billion); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Exhibit 30: Chart on End-user - Market share 2023-2028 (%); Exhibit 31: Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Exhibit 32: Chart on Comparison by End-user; Exhibit 33: Data Table on Comparison by End-user; 6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028; Exhibit 34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion); Exhibit 35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion); Exhibit 36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); 6.4 Academic institutes and research laboratories - Market size and forecast 2023-2028; Exhibit 38: Chart on Academic institutes and research laboratories - Market size and forecast 2023-2028 ($ billion); Exhibit 39: Data Table on Academic institutes and research laboratories - Market size and forecast 2023-2028 ($ billion); Exhibit 40: Chart on Academic institutes and research laboratories - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Academic institutes and research laboratories - Year-over-year growth 2023-2028 (%); 6.5 CRO - Market size and forecast 2023-2028; Exhibit 42: Chart on CRO - Market size and forecast 2023-2028 ($ billion); Exhibit 43: Data Table on CRO - Market size and forecast 2023-2028 ($ billion); Exhibit 44: Chart on CRO - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on CRO - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Exhibit 46: Market opportunity by End-user ($ billion); Exhibit 47: Data Table on Market opportunity by End-user ($ billion)
7 Market Segmentation by Delivery Mode: 7.1 Market segments; Exhibit 48: Chart on Delivery Mode - Market share 2023-2028 (%); Exhibit 49: Data Table on Delivery Mode - Market share 2023-2028 (%); 7.2 Comparison by Delivery Mode; Exhibit 50: Chart on Comparison by Delivery Mode; Exhibit 51: Data Table on Comparison by Delivery Mode; 7.3 Ex-vivo - Market size and forecast 2023-2028; Exhibit 52: Chart on Ex-vivo - Market size and forecast 2023-2028 ($ billion); Exhibit 53: Data Table on Ex-vivo - Market size and forecast 2023-2028 ($ billion); Exhibit 54: Chart on Ex-vivo - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Ex-vivo - Year-over-year growth 2023-2028 (%); 7.4 In-vivo - Market size and forecast 2023-2028; Exhibit 56: Chart on In-vivo - Market size and forecast 2023-2028 ($ billion); Exhibit 57: Data Table on In-vivo - Market size and forecast 2023-2028 ($ billion); Exhibit 58: Chart on In-vivo - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on In-vivo - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Delivery Mode; Exhibit 60: Market opportunity by Delivery Mode ($ billion); Exhibit 61: Data Table on Market opportunity by Delivery Mode ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 65: Chart on Geographic comparison; Exhibit 66: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 UK - Market size and forecast 2023-2028; Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 Canada - Market size and forecast 2023-2028; Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 103: Market opportunity By Geographical Landscape ($ billion); Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 105: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 106: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 107: Overview on factors of disruption; 11.4 Industry risks; Exhibit 108: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 109: Vendors covered; 12.2 Market positioning of vendors; Exhibit 110: Matrix on vendor position and classification; 12.3 AstraZeneca PLC; Exhibit 111: AstraZeneca PLC - Overview; Exhibit 112: AstraZeneca PLC - Product / Service; Exhibit 113: AstraZeneca PLC - Key news; Exhibit 114: AstraZeneca PLC - Key offerings; 12.4 Caribou Biosciences Inc.; Exhibit 115: Caribou Biosciences Inc. - Overview; Exhibit 116: Caribou Biosciences Inc. - Product / Service; Exhibit 117: Caribou Biosciences Inc. - Key offerings; 12.5 Cellectis SA; Exhibit 118: Cellectis SA - Overview; Exhibit 119: Cellectis SA - Product / Service; Exhibit 120: Cellectis SA - Key offerings; 12.6 Cibus; Exhibit 121: Cibus - Overview; Exhibit 122: Cibus - Product / Service; Exhibit 123: Cibus - Key offerings; 12.7 Danaher Corp.; Exhibit 124: Danaher Corp. - Overview; Exhibit 125: Danaher Corp. - Business segments; Exhibit 126: Danaher Corp. - Key news; Exhibit 127: Danaher Corp. - Key offerings; Exhibit 128: Danaher Corp. - Segment focus; 12.8 Editas Medicine Inc.; Exhibit 129: Editas Medicine Inc. - Overview; Exhibit 130: Editas Medicine Inc. - Product / Service; Exhibit 131: Editas Medicine Inc. - Key offerings; 12.9 Egenesis; Exhibit 132: Egenesis - Overview; Exhibit 133: Egenesis - Product / Service; Exhibit 134: Egenesis - Key offerings; 12.10 GenScript Biotech Corp.; Exhibit 135: GenScript Biotech Corp. - Overview; Exhibit 136: GenScript Biotech Corp. - Business segments; Exhibit 137: GenScript Biotech Corp. - Key offerings; Exhibit 138: GenScript Biotech Corp. - Segment focus; 12.11 Horizon Discovery Ltd.; Exhibit 139: Horizon Discovery Ltd. - Overview; Exhibit 140: Horizon Discovery Ltd. - Business segments; Exhibit 141: Horizon Discovery Ltd. - Key offerings; Exhibit 142: Horizon Discovery Ltd. - Segment focus; 12.12 Intellia Therapeutics Inc.; Exhibit 143: Intellia Therapeutics Inc. - Overview; Exhibit 144: Intellia Therapeutics Inc. - Product / Service; Exhibit 145: Intellia Therapeutics Inc. - Key offerings; 12.13 Merck KGaA; Exhibit 146: Merck KGaA - Overview; Exhibit 147: Merck KGaA - Business segments; Exhibit 148: Merck KGaA - Key news; Exhibit 149: Merck KGaA - Key offerings; Exhibit 150: Merck KGaA - Segment focus; 12.14 New England Biolabs Inc.; Exhibit 151: New England Biolabs Inc. - Overview; Exhibit 152: New England Biolabs Inc. - Product / Service; Exhibit 153: New England Biolabs Inc. - Key news; Exhibit 154: New England Biolabs Inc. - Key offerings; 12.15 Precision BioSciences Inc.; Exhibit 155: Precision BioSciences Inc. - Overview; Exhibit 156: Precision BioSciences Inc. - Business segments; Exhibit 157: Precision BioSciences Inc. - Key offerings; Exhibit 158: Precision BioSciences Inc. - Segment focus; 12.16 Sangamo Therapeutics Inc.; Exhibit 159: Sangamo Therapeutics Inc. - Overview; Exhibit 160: Sangamo Therapeutics Inc. - Product / Service; Exhibit 161: Sangamo Therapeutics Inc. - Key offerings; 12.17 Takara Bio Inc.; Exhibit 162: Takara Bio Inc. - Overview; Exhibit 163: Takara Bio Inc. - Business segments; Exhibit 164: Takara Bio Inc. - Key offerings; Exhibit 165: Takara Bio Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 166: Inclusions checklist; Exhibit 167: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 168: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 169: Research methodology; Exhibit 170: Validation techniques employed for market sizing; Exhibit 171: Information sources; 13.5 List of abbreviations; Exhibit 172: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Delivery Mode; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global genome editing market 2018 - 2022 ($ billion); Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion); Exhibits20: Historic Market Size - Delivery mode Segment 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on End-user - Market share 2023-2028 (%); Exhibits31: Data Table on End-user - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by End-user; Exhibits33: Data Table on Comparison by End-user; Exhibits34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion); Exhibits35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion); Exhibits36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Academic institutes and research laboratories - Market size and forecast 2023-2028 ($ billion); Exhibits39: Data Table on Academic institutes and research laboratories - Market size and forecast 2023-2028 ($ billion); Exhibits40: Chart on Academic institutes and research laboratories - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Academic institutes and research laboratories - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on CRO - Market size and forecast 2023-2028 ($ billion); Exhibits43: Data Table on CRO - Market size and forecast 2023-2028 ($ billion); Exhibits44: Chart on CRO - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on CRO - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by End-user ($ billion); Exhibits47: Data Table on Market opportunity by End-user ($ billion); Exhibits48: Chart on Delivery Mode - Market share 2023-2028 (%); Exhibits49: Data Table on Delivery Mode - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by Delivery Mode; Exhibits51: Data Table on Comparison by Delivery Mode; Exhibits52: Chart on Ex-vivo - Market size and forecast 2023-2028 ($ billion); Exhibits53: Data Table on Ex-vivo - Market size and forecast 2023-2028 ($ billion); Exhibits54: Chart on Ex-vivo - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Ex-vivo - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on In-vivo - Market size and forecast 2023-2028 ($ billion); Exhibits57: Data Table on In-vivo - Market size and forecast 2023-2028 ($ billion); Exhibits58: Chart on In-vivo - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on In-vivo - Year-over-year growth 2023-2028 (%); Exhibits60: Market opportunity by Delivery Mode ($ billion); Exhibits61: Data Table on Market opportunity by Delivery Mode ($ billion); Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits65: Chart on Geographic comparison; Exhibits66: Data Table on Geographic comparison; Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits103: Market opportunity By Geographical Landscape ($ billion); Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits105: Impact of drivers and challenges in 2023 and 2028; Exhibits106: Overview on Criticality of inputs and Factors of differentiation; Exhibits107: Overview on factors of disruption; Exhibits108: Impact of key risks on business; Exhibits109: Vendors covered; Exhibits110: Matrix on vendor position and classification; Exhibits111: AstraZeneca PLC - Overview; Exhibits112: AstraZeneca PLC - Product / Service; Exhibits113: AstraZeneca PLC - Key news; Exhibits114: AstraZeneca PLC - Key offerings; Exhibits115: Caribou Biosciences Inc. - Overview; Exhibits116: Caribou Biosciences Inc. - Product / Service; Exhibits117: Caribou Biosciences Inc. - Key offerings; Exhibits118: Cellectis SA - Overview; Exhibits119: Cellectis SA - Product / Service; Exhibits120: Cellectis SA - Key offerings; Exhibits121: Cibus - Overview; Exhibits122: Cibus - Product / Service; Exhibits123: Cibus - Key offerings; Exhibits124: Danaher Corp. - Overview; Exhibits125: Danaher Corp. - Business segments; Exhibits126: Danaher Corp. - Key news; Exhibits127: Danaher Corp. - Key offerings; Exhibits128: Danaher Corp. - Segment focus; Exhibits129: Editas Medicine Inc. - Overview; Exhibits130: Editas Medicine Inc. - Product / Service; Exhibits131: Editas Medicine Inc. - Key offerings; Exhibits132: Egenesis - Overview; Exhibits133: Egenesis - Product / Service; Exhibits134: Egenesis - Key offerings; Exhibits135: GenScript Biotech Corp. - Overview; Exhibits136: GenScript Biotech Corp. - Business segments; Exhibits137: GenScript Biotech Corp. - Key offerings; Exhibits138: GenScript Biotech Corp. - Segment focus; Exhibits139: Horizon Discovery Ltd. - Overview; Exhibits140: Horizon Discovery Ltd. - Business segments; Exhibits141: Horizon Discovery Ltd. - Key offerings; Exhibits142: Horizon Discovery Ltd. - Segment focus; Exhibits143: Intellia Therapeutics Inc. - Overview; Exhibits144: Intellia Therapeutics Inc. - Product / Service; Exhibits145: Intellia Therapeutics Inc. - Key offerings; Exhibits146: Merck KGaA - Overview; Exhibits147: Merck KGaA - Business segments; Exhibits148: Merck KGaA - Key news; Exhibits149: Merck KGaA - Key offerings; Exhibits150: Merck KGaA - Segment focus; Exhibits151: New England Biolabs Inc. - Overview; Exhibits152: New England Biolabs Inc. - Product / Service; Exhibits153: New England Biolabs Inc. - Key news; Exhibits154: New England Biolabs Inc. - Key offerings; Exhibits155: Precision BioSciences Inc. - Overview; Exhibits156: Precision BioSciences Inc. - Business segments; Exhibits157: Precision BioSciences Inc. - Key offerings; Exhibits158: Precision BioSciences Inc. - Segment focus; Exhibits159: Sangamo Therapeutics Inc. - Overview; Exhibits160: Sangamo Therapeutics Inc. - Product / Service; Exhibits161: Sangamo Therapeutics Inc. - Key offerings; Exhibits162: Takara Bio Inc. - Overview; Exhibits163: Takara Bio Inc. - Business segments; Exhibits164: Takara Bio Inc. - Key offerings; Exhibits165: Takara Bio Inc. - Segment focus; Exhibits166: Inclusions checklist; Exhibits167: Exclusions checklist; Exhibits168: Currency conversion rates for US$; Exhibits169: Research methodology; Exhibits170: Validation techniques employed for market sizing; Exhibits171: Information sources; Exhibits172: List of abbreviations